相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy
Yayan T. Sundara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes
Xiaojun He et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2017)
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial
Anne Gomez-Brouchet et al.
ONCOIMMUNOLOGY (2017)
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
Cindy L. Schwartz et al.
PEDIATRIC BLOOD & CANCER (2016)
Future directions in the treatment of osteosarcoma
Michael W. Bishop et al.
CURRENT OPINION IN PEDIATRICS (2016)
Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward
Joanne P. Lagmay et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial
Sophie Piperno-Neumann et al.
LANCET ONCOLOGY (2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa M. Marina et al.
LANCET ONCOLOGY (2016)
Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133A Report From the Children's Oncology Group Bone Tumor Committee
Michael W. Bishop et al.
PEDIATRIC BLOOD & CANCER (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
A comparative study between limb-salvage and amputation for treating osteosarcoma
Xiaojuan Li et al.
JOURNAL OF BONE ONCOLOGY (2016)
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
L. Paoluzzi et al.
CLINICAL SARCOMA RESEARCH (2016)
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan S. Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
Michael S. Isakoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
Danielle M. Lussier et al.
JOURNAL OF IMMUNOTHERAPY (2015)
Germline TP53 Variants and Susceptibility to Osteosarcoma
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
Giovanni Grignani et al.
LANCET ONCOLOGY (2015)
Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients CASE-CONTROL STUDY
H. Wafa et al.
BONE & JOINT JOURNAL (2015)
Germline TP53 Variants and Susceptibility to Osteosarcoma
Lisa Mirabello et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Danielle M. Lussier et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2
David S. Geller et al.
CLINICAL CANCER RESEARCH (2015)
What Was the Survival of Megaprostheses in Lower Limb Reconstructions After Tumor Resections?
Rodolfo Capanna et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
Navigated Pelvic Osteotomy and Tumor Resection
Amir Sternheim et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2015)
Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma
Vincent I. Poon et al.
CLINICAL SARCOMA RESEARCH (2015)
Computer-assisted surgery in orthopedic oncology Technique, indications, and a descriptive study of 130 cases
Jasper G. Gerbers et al.
ACTA ORTHOPAEDICA (2014)
Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 Cases
Shintaro Iwata et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Ganglioside GD2 as a Therapeutic Target for Antibody-Mediated Therapy in Patients With Osteosarcoma
Michael Roth et al.
CANCER (2014)
Osteosarcoma treatment - Where do we stand? A state of the art review
Anja Luetke et al.
CANCER TREATMENT REVIEWS (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
Exomics and immunogenics Bridging mutational load and immune checkpoints efficacy
Stephane Champiat et al.
ONCOIMMUNOLOGY (2014)
Haptic Robot-assisted Surgery Improves Accuracy of Wide Resection of Bone Tumors: A Pilot Study
Fazel Khan et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2013)
CompressA® Knee Arthroplasty Has 80% 10-year Survivorship and Novel Forms of Bone Failure
John H. Healey et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2013)
Surgical Technique: Computer-generated Custom Jigs Improve Accuracy of Wide Resection of Bone Tumors
Fazel A. Khan et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2013)
Can computer navigation-assisted surgery reduce the risk of an intralesional margin and reduce the rate of local recurrence in patients with a tumour of the pelvis or sacrum?
L. Jeys et al.
BONE & JOINT JOURNAL (2013)
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
G. Grignani et al.
ANNALS OF ONCOLOGY (2012)
Use of a patient-specific CAD/CAM surgical jig in extremity bone tumor resection and custom prosthetic reconstruction
K. C. Wong et al.
COMPUTER AIDED SURGERY (2012)
Frontline Treatment of Localized Osteosarcoma Without Methotrexate Results of the St. Jude Children's Research Hospital OS99 Trial
Najat C. Daw et al.
CANCER (2011)
Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial
H. Assi et al.
Current Oncology (2011)
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Jakob K. Anninga et al.
EUROPEAN JOURNAL OF CANCER (2011)
Palliative therapy for osteosarcoma
Costantino Errani et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
RANKL Expression Is Related to Treatment Outcome of Patients With Localized, High-Grade Osteosarcoma
Jun Ah Lee et al.
PEDIATRIC BLOOD & CANCER (2011)
Cemented Distal Femoral Endoprostheses for Musculoskeletal Tumor Improved Survival of Modular versus Custom Implants
Adam J. Schwartz et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2010)
The Role of Interferons in the Treatment of Osteosarcoma
Jeremy Whelan et al.
PEDIATRIC BLOOD & CANCER (2010)
Initial Testing (Stage 1) of the Multi-Targeted Kinase Inhibitor Sorafenib by the Pediatric Preclinical Testing Program
Stephen T. Keir et al.
PEDIATRIC BLOOD & CANCER (2010)
Addition of Muramyl Tripeptide to Chemotherapy for Patients With Newly Diagnosed Metastatic Osteosarcoma
Alexander J. Chou et al.
CANCER (2009)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
Lisa Mirabello et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways
Ymera Pignochino et al.
MOLECULAR CANCER (2009)
Osteosarcoma: The COSS Experience
Stefan Bielack et al.
PEDIATRIC AND ADOLESCENT OSTEOSARCOMA (2009)
Surgical inaccuracy of tumor resection and reconstruction within the pelvis - An experimental study
Olivier Cartiaux et al.
ACTA ORTHOPAEDICA (2008)
Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis
L. M. Jeys et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2008)
Osteosarcoma: The addition of muramyl tripeptide to chemotherapy improves overall survival - A report from the Children's Oncology Group
Paul A. Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A review of clinical and molecular prognostic factors in osteosarcoma
Jonathan C. M. Clark et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: A 27-year experience in a single institution
Gaetano Bacci et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B
K. Mori et al.
JOURNAL OF PATHOLOGY (2007)
The use of massive bone allograft with intramedullary free fibular flap for limb salvage in a pediatric and adolescent population
Steven L. Moran et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Interferon-α as the only adjuvant treatment in high-grade osteosarcoma:: Long term results of the Karolinska Hospital series
CR Müller et al.
ACTA ONCOLOGICA (2005)
Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate
PA Meyers et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Osteosarcoma relapse after combined modality therapy:: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS)
B Kempf-Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Allografts about the knee in young patients with high-grade sarcoma
BE Brigman et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Biology and therapeutic advances for pediatric osteosarcoma
N Marina et al.
ONCOLOGIST (2004)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
N Jaffe et al.
CANCER (2002)
Surgical outcomes in osteosarcoma
RJ Grimer et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2002)
分享论文
